ARTICLE | Company News
Halozyme management update
December 6, 2010 8:00 AM UTC
Halozyme Therapeutics Inc. (NASDAQ:HALO), San Diego, Calif. Business: Endocrine, Cancer, Dermatology Promoted: H. Michael Shepard to CSO from VP of discovery research Resigned: Robert Little as VP and...